Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.58 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | LAP3 | P28838 | 2/20 | 0.50 |
| ▸ | ANPEP | P15144 | 2/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | XIAP | P98170 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | SCN4A | P35499 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4950704 | 1.00 | EPHX1 (0.62) | EPHX1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL4950924 | 1.00 | EPHX1 (0.62) | EPHX1SLC6A2TAAR1MAOASLC6A4 | |
| Iodide SCHEMBL28946993 | 0.98 | EPHX1 (0.60) | EPHX1SLC6A2TAAR1MAOASLC6A4 | |
| Hydrochloric Acid SCHEMBL28001158 | 0.98 | EPHX1 (0.60) | EPHX1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL6188434 | 0.88 | SRR (0.49) | EPHX1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL11512652 | 0.84 | TAAR1 (0.53) | EPHX1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL16389766 | 0.80 | SLC6A4 (0.44) | EPHX1TAAR1SLC6A4CYP2D6 | |
| SCHEMBL1049748 | 0.78 | EPHX1 (0.58) | EPHX1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL1204850 | 0.78 | SLC6A2 (0.54) | EPHX1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL7265649 | 0.78 | ANPEP (0.47) | EPHX1SLC6A2TAAR1MAOASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 449 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250145472-A1 | METHOD FOR GENERATING CARBON DIOXIDE | KOBE GAKUIN EDUCATIONAL FOUNDATION (JP) | 2025-05-08 | — | — | US | claimed |
| EP-4480568-A1 | METHOD FOR GENERATING CARBON DIOXIDE | Kobe Gakuin Educational Foundation (JP) | 2024-12-25 | — | — | EP | claimed |
| WO-2023153506-A1 | METHOD FOR GENERATING CARBON DIOXIDE | 学校法人神戸学院 | 2023-08-17 | — | — | WO | claimed |
| CN-116367565-A | Quasi two-dimensional perovskite nanocrystalline modified three-dimensional perovskite solar cell | 河北工业大学 | 2023-06-30 | — | — | CN | claimed |
| CN-110396115-A | The application of the fire retardant of six (4- methoxyphenethylamine base) rings, three phosphonitrile and preparation method | UNIV WEIFANG MEDICAL | 2019-11-01 | — | — | CN | claimed |
| CN-106632368-B | A kind of preparation method of irinotecan hydrochloride | 上海金和生物制药有限公司 | 2019-03-08 | — | — | CN | claimed |
| CN-108899155-A | A kind of preparation method of rare earth base semiconductor magnetic material | 吴江市聚盈电子材料科技有限公司 | 2018-11-27 | — | — | CN | claimed |
| EP-2923692-B1 | Beta-amino ester compounds and uses thereof | LIVING PROOF INC (US) | 2018-05-30 | — | — | EP | claimed |
| CN-106632368-A | Preparation method of irinotecan hydrochloride | 上海金和生物制药有限公司 | 2017-05-10 | — | — | CN | claimed |
| CN-104130257-B | One-dimensional organic semiconductor spiral nano-wires with fluorescence response upon organic amine gases, and preparation method and application thereof | 中国科学院化学研究所 | 2017-02-15 | — | — | CN | claimed |
| US-20030082830-A1 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-05-01 | — | — | US | claimed |
| US-6448443-B1 | GENERATED FROM DIVERSIFIABLE SCAFFOLDS SYNTHESIZED FROM THE PYRIDINE-BASED TEMPLATE ISONICOTINAMIDE; ALSO PROVIDES A NOVEL ORTHO-NITROBENZYL PHOTOLINKER; SYNTHESIZED FROM A SHIKIMIC ACID BASED EPOXYOL TEMPLATE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2002-09-10 | — | — | US | claimed |
| WO-2002043675-A2 | IMMOBILISATION OF ACTIVE AGENTS ON FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-06-06 | — | — | WO | claimed |
| EP-1076649-A1 | ISOQUINOLINE COMPOUND MELANOCORTIN RECEPTOR LIGANDS AND METHODS OF USING SAME | TREGA BIOSCIENCES, INC. (US) | 2001-02-21 | — | — | EP | claimed |
| US-6127381-A | A MELANOCORTIN RECEPTOR LIGAND FOR REGULATING FOOD INTAKE AND BODY WEIGHT, REGULATING CYTOKINE ACTIVITY, ANTI-INFLAMMATORY ACTIVITY | LION BIOSCIENCE AG (DE) | 2000-10-03 | — | — | US | claimed |
| EP-0674232-B1 | Recording sheets | XEROX CORP (US) | 2000-05-31 | — | — | EP | claimed |
| WO-2000006525-A9 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | HARVARD COLLEGE (US) | 2000-04-20 | — | — | WO | claimed |
| WO-2000006525-A2 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-02-10 | — | — | WO | claimed |
| WO-1999055679-A1 | ISOQUINOLINE COMPOUND MELANOCORTIN RECEPTOR LIGANDS AND METHODS OF USING SAME | TREGA BIOSCIENCES, INC. (US) | 1999-11-04 | — | — | WO | claimed |
| EP-0167451-B1 | A NEW PROCESS FOR PREPARING NOVEL N-(ACYLOXY-ALKOXY) CARBONYL DERIVATIVES USEFUL AS BIOREVERSIBLE PRODRUG MOIETIES FOR PRIMARY AND SECONDARY AMINE FUNCTIONS IN DRUGS | MERCK & CO. INC. (US) | 1990-10-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030082830-A1 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | TKFC, NISCH, PTGIS | EPHX1 19/4885SLC6A2 1819/4885TAAR1 2413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.